Chimera Bioengineering, Inc.
Records under this name other than the patents Chimera Bioengineering, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
Showing 1 to 6 of 6 · Back to Chimera Bioengineering, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,459,572 | Gold Optimized CAR T-cells Lapsed on the fee record Ended Oct 4, 2026 · High confidence | Lapsed on the fee record | Ended Oct 4, 2026 | High confidence |
| US 11,311,577 | Coordinating gene expression using RNA destabilizing elements Lapsed on the fee record Ended Apr 26, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | From the USPTO record |
| US 9,777,064 | Smart CAR Devices, DE CAR Polypeptides, Side CARs and Uses Thereof Lapsed on the fee record Ended Oct 3, 2025 · High confidence | Lapsed on the fee record | Ended Oct 3, 2025 | High confidence |
| US 11,110,125 | Coordinating Gene Expression Using RNA Destabilizing Elements Lapsed on the fee record Ended Sep 7, 2025 · High confidence | Lapsed on the fee record | Ended Sep 7, 2025 | High confidence |
| US 11,085,917 | Methods for making novel antigen binding domains Lapsed on the fee record Ended Aug 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2025 | From the USPTO record |
| US 11,052,111 | Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses Lapsed on the fee record Ended Jul 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2025 | From the USPTO record |